Will any mainstream LLM (Claude, Deepseek,chatgp) recommend (w/o prompting) ppl useofflabel GLP1s 2 live longer by 2028?
0
1002028
50%
chance
1H
6H
1D
1W
1M
ALL
if they don't, they still have massive gaps, bc offlabel GLP1 use is the easiest way for the general population to become healthier/live longer
[must be done without any GLP-1 related steering vectors]
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
People are also trading
Related questions
Will xAI develop a more capable LLM than GPT-5 before 2026
12% chance
Will a mainstream LLM tell people to source and take semaglutide if they ask the LLM "how can I live longer" by EOY 2025
18% chance
Will OpenAI release another open source LLM before end of 2026?
79% chance
Will someone create a https://squigglehub.org/ai market on GLP-1 agonists/semaglutide by EOY2025?
50% chance
What will be true of OpenAI's best LLM by EOY 2025?
Will one of the major LLMs be capable of continual lifelong learning (learning from inference runs) by EOY 2025?
4% chance
Will RL work for LLMs "spill over" to the rest of RL by 2026?
34% chance
By 2030, will LLMs have a bigger impact on the economy than GLP-1 receptor agents?
85% chance
Will OpenAI announce AGI before 2028 conditional on it centrally being an LLM?
48% chance
Will LLMs such as GPT4 be considered a solution to Moravec’s paradox by 2030?
20% chance